Allicular simulation three-dimensional scaffold material for regeneration and repair of salivary glands as well as preparation method and application of alveolar simulation three-dimensional scaffold material
By using astragalus-imitated acinar three-dimensional scaffolds of astragalus polysaccharide, silk fibroin and collagen in salivary gland regeneration, combined with low-temperature 3D printing and freeze-drying technology, the problem of salivary gland dysfunction was solved, and the recovery of gland regeneration and salivary secretion functions was achieved. , improve facial image.
Patent Information
- Application Number
- CN202411051740.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art is difficult to effectively treat salivary gland dysfunction, especially glandular function damage and facial image problems caused by parotid tumor surgery, and there is a lack of effective methods that can promote salivary secretion and tissue regeneration.
Develop a three-dimensional scaffold material that contains astragalus polysaccharide, silk fibroin and collagen, prepared by low-temperature 3D printing and fractional freeze-drying technology to form a biological scaffold with micropore structure and drug sustained release system for salivary glands Regeneration and repair.
This material can effectively promote cell recruitment and proliferation, reduce inflammatory response, restore salivary secretion function, maintain gland structure, improve facial morphology, and significantly improve salivary gland regeneration effect.
Smart Images

Figure CN119055837A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical engineering, and in particular relates to an acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair, and a preparation method and application thereof. Background Art
[0002] The salivary gland is the main functional organ for secreting saliva in the oral cavity. Clinically, tumors, trauma, inflammation, etc. may cause functional or organic damage to the gland, resulting in reduced saliva secretion, oral burning sensation, increased incidence of oral infection, affecting functions such as chewing and swallowing, and in severe cases causing systemic functional impairment, thereby reducing the quality of life. The parotid gland is the largest pair of salivary glands, and 80% of salivary gland tumors occur in the parotid gland. Surgical resection is still the main means of treating parotid gland tumors. Due to the special location of the parotid gland, in addition to impaired secretion function, it can also cause facial depression and affect the image after surgery. For salivary secretion dysfunction, clinical treatment methods are limited, mainly including the use of artificial saliva, saliva inducing agents or physical therapy to relieve symptoms, which cannot completely solve the problem. For patients with damaged salivary gland tissue and cells, there is still a lack of effective treatment methods in theory. Therefore, it is very necessary to develop a biological scaffold with a certain volume that can be implanted to support facial morphology after parotid gland defect, effectively recruit cells to achieve glandular tissue regeneration, and relieve local inflammatory state to promote saliva secretion function.
[0003] Regenerative medicine and tissue engineering have brought a way out for salivary gland regeneration. It is possible to use tissue engineering technology to prepare glandular organs with biological activity and similar structure and function to salivary glands. The scaffold materials reported to be used in salivary gland tissue engineering regeneration research mainly include collagen, chitosan and polylactic acid-co-glycolic acid copolymer. Collagen is widely used as the main component of the extracellular matrix. It has low immunogenicity and degradability, and can induce salivary gland cells to adhere and grow, and can form acinar-like structures during in vitro culture. Silk fibroin is a natural protein extracted from silk. Silk fibroin contains a special tripeptide structure closely related to cell adhesion, namely, the arginine-glycine-aspartic acid peptide structure, which can promote cell migration, adhesion and proliferation on the surface of the material. Studies have shown that the combination of silk fibroin and collagen can significantly improve the mechanical strength and degradation time of the material, and promote the interaction between the scaffold and the tissue.
[0004] Chronic inflammatory state of salivary glands is the main cause of reduced secretory function, so the key to achieve regeneration is to improve the local inflammatory state of the glands. Traditional Chinese medicine has outstanding advantages in the treatment of dry mouth. Astragalus polysaccharide is a water-soluble heteropolysaccharide extracted, concentrated and purified from the dried root of Astragalus. It is the main component of Astragalus for its pharmacological effects. It is mainly composed of glucose, fructose, hexuronic acid, galacturonic acid and other components. It can be used as an immunopotentiator or regulator, and has anti-inflammatory, antiviral, anti-tumor, anti-aging, anti-radiation, anti-stress and antioxidant effects. Studies have found that Astragalus polysaccharide can promote saliva secretion in rats with spleen deficiency and water retention through the p38MAPK / c-Jun / AOP5 pathway. Astragalus polysaccharide can also reduce the side effects of radiotherapy in patients with head and neck tumors and improve the immune level of the patient's body. Therefore, Astragalus polysaccharide is a potential pleiotropic growth factor that can be used for salivary gland regeneration and function promotion. When preparing implant materials, adding Astragalus polysaccharide components can significantly promote the regeneration effect.
[0005] Prior art CN109045360A discloses: a method for preparing a collagen-silk fibroin-chitosan / astragalus polysaccharide engineered skin three-dimensional scaffold, the method comprising the following steps: 1) dissolving collagen and silk fibroin in distilled water respectively to prepare a 3.0-4.0% collagen aqueous solution and a 1.0-2.0% silk fibroin aqueous solution; 2) mixing the collagen aqueous solution and the silk fibroin aqueous solution at a solute-protein mass ratio of 1:1-5:1, adding the prepared astragalus polysaccharide / chitosan microspheres to the mixed solution, and stirring and mixing thoroughly; 3) adding the above-mentioned mixed solution containing microspheres into a pre-prepared mold container, pre-freezing and forming at -30~-20°C, and then vacuum drying at -65~-55°C for 48h~72h to obtain an engineered skin three-dimensional scaffold. This method for preparing an engineered skin three-dimensional scaffold cleverly uses chitosan microspheres to encapsulate astragalus polysaccharide to construct a sustained-release system, and composites it on a collagen-silk fibroin three-dimensional scaffold to achieve the purpose of promoting vascularization of the biocomposite scaffold. However, this technology does not involve the application of salivary glands.
[0006] The salivary gland is a complete organ with certain biological structures and functions. Therefore, the key to the study of salivary gland regeneration is to make the structural design of the material as close to the natural gland morphology as possible. The salivary gland is mainly composed of many alveoli and graded ducts. The alveoli are composed of "chambers" in which the polarized glandular epithelial cells can form saliva. The function of the duct is mainly to collect and secrete saliva. Therefore, when preparing salivary gland regeneration materials, having many microscopic "chambers" and excretion channels is the focus and difficulty of the research. Summary of the invention
[0007] The present invention first provides a three-dimensional acinus-mimicking scaffold material for salivary gland regeneration and repair, the material comprising: astragalus polysaccharide, silk fibroin and collagen;
[0008] Optionally, the mass fractions of the astragalus polysaccharide, silk fibroin and collagen are 0.01-9.5%, 35-90% and 10%-40% respectively.
[0009] In certain embodiments, the mass fractions of astragalus polysaccharide, silk fibroin and collagen are 4-5%, 59-60% and 35-36% respectively.
[0010] In certain embodiments, the mass fractions of astragalus polysaccharide, silk fibroin and collagen are 4.8%, 59.5% and 35.7% respectively.
[0011] In certain embodiments, there is a two-dimensional pore structure in the material, and the micropores mimic natural alveoli.
[0012] In certain embodiments, the material can achieve sustained release of astragalus polysaccharide.
[0013] The present invention also provides a method for preparing the above-mentioned acinar-mimicking three-dimensional scaffold material for salivary gland regeneration and repair, the method comprising the steps of low-temperature 3D printing and fractional freeze-drying.
[0014] The present invention also provides a method for preparing the above-mentioned acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair, the method comprising the following steps:
[0015] a. Extracting proteins from biological materials;
[0016] b. Use low-temperature 3D printing to shape materials, design printing models and set 3D printing parameters;
[0017] c. Setting freeze-drying parameters and using freeze-drying to obtain the microporous structure and drug loading space within the material;
[0018] d. Using freeze drying in batches to evenly load astragalus polysaccharide;
[0019] Optionally, the biomaterial of step a comprises bovine tendon and natural silk.
[0020] In some embodiments, in step b, the setting parameters of 3D printing are: printing filling gap 1.3-1.5mm; edge gap 0.58-0.75mm, and the temperature of the receiving device is controlled at -30°C to -10°C.
[0021] In certain embodiments, in step c, the freeze-drying treatment conditions are: condensation temperature < -60°C, vacuum degree <15Pa; in step d, freeze-drying is performed twice before and after loading astragalus polysaccharide.
[0022] Finally, the present invention provides the application of the above-mentioned three-dimensional scaffold material for salivary gland regeneration and repair or the above-mentioned preparation method, wherein the application is one or more of a) to d);
[0023] a) Used for salivary gland regeneration and repair;
[0024] b) Preparation of drugs for salivary gland regeneration and repair;
[0025] c) For the treatment of salivary gland tumors, chronic inflammation of the salivary glands, or to alleviate the side effects of radiotherapy in patients with head and neck tumors;
[0026] d) Preparation of a medicament for treating salivary gland tumors, chronic inflammation of the salivary glands or for alleviating the side effects of radiotherapy in patients with head and neck tumors;
[0027] Optionally, the method is optionally used for non-diagnostic purposes or non-therapeutic purposes.
[0028] Compared with the prior art, the present invention has at least the following beneficial effects:
[0029] In the present invention, astragalus polysaccharide, collagen and silk fibroin are combined for salivary gland regeneration. Silk fibroin and collagen provide an extracellular matrix framework for salivary gland regeneration, and the multi-effect promoting effect of astragalus polysaccharide on cells is utilized to enhance the performance of the scaffold. The composite scaffold can effectively achieve cell recruitment, promote cell proliferation and orderly arrangement, and reduce inflammatory response. The material is formed by low-temperature 3D printing, and macroscopic pores between the wire bundles are prepared to realize the function of the transport channel. The moisture in the material is removed by freeze drying to form microscopic pores that mimic acinus in the wire bundle. After the astragalus polysaccharide is dissolved in water, it is adsorbed on the dry scaffold and freeze-dried again to form a uniform load of the drug. The many microporous structures inside the material are similar to acinus, providing space for orderly growth of cells. The selected materials have natural biological activity and degradability, and the structure also meets the requirements of gland regeneration. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is a flow chart of the preparation of the raw materials of the present invention, showing the pictures and some steps of extracting silk fibroin, collagen and astragalus polysaccharide from natural silk, bovine tendon and astragalus.
[0031] Figure 2 A porous astragalus polysaccharide-collagen-silk fibroin (SCA) scaffold prepared by 3D printing. The pore structure on the surface of the material and the pores and channel structures of different dimensions inside the material can be observed (the red circle is the micropore and the green frame is the channel).
[0032] Figure 3The sustained-release efficiency of astragalus polysaccharides in Example 1 of the present invention is compared with that in Examples 2 and 3 (A); Fourier transform infrared spectroscopy detection (B); CCK-8 detection of the effects of different concentrations of astragalus polysaccharides on the proliferation activity of mesenchymal stem cells MSC (C) and parotid gland epithelial cells GEC (D).
[0033] Figure 4 Parotid gland cells adhere to the scaffold. A: Parotid gland mesenchymal stem cells MSC adhere to the scaffold; B: Parotid gland epithelial cells GEC adhere to the scaffold (arrows point to cells).
[0034] Figure 5 Three-dimensional morphology of parotid cells on the scaffold. A: Calcein-AM-PI staining; B: KRT18 immunofluorescence staining; C: Three-dimensional modeling of cell clusters; D: CCK-8 detection of cell proliferation.
[0035] Figure 6 Effect of stent implantation in vivo. A: A trauma model was prepared in the parotid gland of rats and the stent was implanted; B: The stent maintained the weight of the gland; C: The stent promoted saliva secretion; D: Astragalus polysaccharide on the stent reduced the inflammatory response.
[0036] Figure 7 These are parotid gland histological staining. A: HE staining; B: COL-1 immunohistochemical staining. DETAILED DESCRIPTION
[0037] In order to make the technical problems, technical solutions and advantages to be solved by the present invention more clear, a detailed description will be given below with reference to the accompanying drawings and specific embodiments.
[0038] Example 1
[0039] The silk was treated in 0.5% Na2CO3 solution at 98-100℃ for 30min, repeated 3 times; after drying, it was dissolved in CaCl2·CH3CH2OH·H2O (molar ratio 1:2:8) ternary solvent at (60±2)℃, and the impurities were removed by dialysis, filtration, concentration, centrifugation, and a silk protein solution with a concentration of about 15% was obtained. Fresh bovine tendons were washed, the outer membrane was stripped, the adipose tissue was removed, and the tendons were cleaned, fully crushed, and soaked in 0.05 M Tris buffer for 24 hours to remove soluble impurities. The precipitate was collected by centrifugation, added to an acetic acid solution containing pepsin, fully swollen, and the supernatant was collected by centrifugation. NaCl solution was added for salting out, and the salting out precipitate was collected by centrifugation, dialyzed in deionized water at 4℃ for 5d, and the deionized water was replaced daily to obtain a refined collagen gel with a concentration of 3.3%. Take 36 ml of 15% silk fibroin, mix it with 100 g of 3.3% collagen, add 14 ml of double distilled water and 6 ml of acetic acid, mix well, and make printing ink. The mass percentages of each component are: 3.5% silk fibroin, 2.1% collagen, 4% acetic acid, and 90.4% double distilled water. The initial scaffold morphology formed by low-temperature 3D printing has a printing filling gap of 1.36 mm and an edge gap of 0.68 mm, of which the water accounts for 90.4%. The material is quickly frozen to turn the water into ice crystals, and then a vacuum freeze dryer is used to sublimate the ice crystals in a vacuum at a low temperature and low pressure environment to form a porous structure. The initial scaffold is treated with anhydrous ethanol and 0.01% NaOH solution for 24 hours respectively to neutralize the acetic acid in the material. Astragalus polysaccharide powder is dissolved in double distilled water, adsorbed onto the dry scaffold at a concentration of 5 mg / mL (a 5 mm dry scaffold adsorbs about 40 μl of liquid), and freeze-dried again, and the drug is evenly loaded into the pores of the scaffold. The final dried scaffold components were as follows: 4.8% astragalus polysaccharide, 59.5% silk fibroin, and 35.7% collagen. The scaffold porosity was 86.51%.
[0040] Example 2
[0041] The silk was treated in 0.5% Na2CO3 solution at 98-100℃ for 30min, repeated 3 times; after drying, it was dissolved in CaCl2·CH3CH2OH·H2O (molar ratio 1:2:8) ternary solvent at (60±2)℃, and the ternary solvent was stirred and dissolved. After dialysis, filtration, concentration, centrifugation, and removal of impurities, a silk protein solution with a concentration of about 14% was obtained. Fresh bovine tendons were washed, the outer membrane was stripped, the adipose tissue was removed, and the tendons were cleaned, fully crushed, and soaked in 0.05 M Tris buffer for 24 hours to remove soluble impurities. The precipitate was collected by centrifugation, added to an acetic acid solution containing pepsin, fully swollen, and the supernatant was collected by centrifugation. NaCl solution was added for salting out, and the salting out precipitate was collected by centrifugation. It was dialyzed in deionized water at 4℃ for 5d, and the deionized water was replaced daily to obtain a refined collagen gel with a concentration of 3.3%. Take 36ml of 13% silk fibroin, mix it with 100g of 3.3% collagen, add 14ml double distilled water and 6ml acetic acid, mix well, and make printing ink. The mass percentages of each component are: 3% silk fibroin, 2.1% collagen, 4% acetic acid, and 90.9% double distilled water. The initial scaffold morphology formed by low-temperature 3D printing has a printing filling gap of 1.36mm; the edge gap is 0.68mm, of which the water accounts for 90.9%. The material is quickly frozen to turn the water into ice crystals, and then a vacuum freeze dryer (EYELAFDU-1200) is used to sublimate the ice crystals in a vacuum at low temperature and low pressure to form a porous structure. The initial scaffold is treated with anhydrous ethanol and 0.01% NaOH solution for 24 hours respectively to neutralize the acetic acid in the material. The astragalus polysaccharide powder was dissolved in double distilled water, adsorbed onto the dry stent at a concentration of 3 mg / mL (a 5 mm dry stent adsorbed about 40 μl of liquid), and freeze-dried again. The drug was evenly loaded into the pores of the stent. The final proportions of the components of the dry stent were: astragalus polysaccharide 2.9%, silk fibroin 60.2% and collagen 36.9%. The porosity of the stent was: 86.24%.
[0042] Example 3
[0043] The silk was treated in 0.5% Na2CO3 solution at 98-100℃ for 30min, repeated 3 times; after drying, it was dissolved with CaCl2·CH3CH2OH·H2O (molar ratio 1:2:8) ternary solvent at (60±2)℃, and the ternary solvent was stirred and dissolved. After dialysis, filtration, concentration, centrifugation, and removal of impurities, a silk protein solution with a concentration of about 15% was obtained. Fresh bovine tendons were washed, the outer membrane was stripped, the adipose tissue was removed, and the tendons were cleaned, fully crushed, and soaked in 0.05 M Tris buffer for 24 hours to remove soluble impurities. The precipitate was collected by centrifugation, added to an acetic acid solution containing pepsin, fully swollen, and the supernatant was collected by centrifugation. NaCl solution was added for salting out, and the salting out precipitate was collected by centrifugation. It was dialyzed in deionized water at 4℃ for 5d, and the deionized water was replaced daily to obtain a refined collagen gel with a concentration of 3.3%. Take 36 ml of 15% silk fibroin, mix it with 100 g of 3.3% collagen, add 14 ml of double distilled water and 6 ml of acetic acid, mix well, and make printing ink. The mass percentages of each component are: 3.5% silk fibroin, 2.1% collagen, 4% acetic acid, and 90.4% double distilled water. The initial scaffold morphology formed by low-temperature 3D printing has a printing filling gap of 1.36 mm and an edge gap of 0.68 mm, of which the water accounts for 90.4%. The material is quickly frozen to turn the water into ice crystals, and then a vacuum freeze dryer is used to sublimate the ice crystals in a vacuum at a low temperature and low pressure environment to form a porous structure. The initial scaffold is treated with anhydrous ethanol and 0.01% NaOH solution for 24 hours respectively to neutralize the acetic acid in the material. Astragalus polysaccharide powder is dissolved in double distilled water, adsorbed onto the dry scaffold at a concentration of 1 mg / mL (a 5mm dry scaffold adsorbs about 35μl of liquid), and freeze-dried again, and the drug is evenly loaded into the pores of the scaffold. The final dried scaffold components were as follows: 1.0% astragalus polysaccharide, 59.7% silk fibroin, and 39.3% collagen. The scaffold porosity was 87.35%.
[0044] The comparative results of the drug sustained release effects of Examples 1, 2 and 3 of the present invention show:
[0045] All three implementation cases had a burst release in the first 6 hours, and the drug was released slowly in the following period. Comparing the drug release efficiency of implementation 1 with that of implementation 2 and 3, the drug concentration in the surrounding culture medium after release in implementation 1 was maintained between 0.4-0.6 mg / mL ( Figure 3 A), which neither causes toxicity to cells nor increases the activity of GEC within the maximum concentration range ( Figure 3 C, D). Therefore, compared with Examples 2 and 3, Example 1 has a suitable component ratio, the highest sustained-release drug concentration, and promotes the proliferation of inoculated cells, making it the optimal example.
[0046] Figure 2This is the appearance of the repair material. It can be observed that the surface of the scaffold material has a uniformly distributed pore structure, which provides a certain space for cell adhesion. The interior has a rich alveolar-like pore structure (red circle) and also has macroscopic pore channels formed by printing (green circle), which provide space for orderly cell growth and the transportation of metabolites. Figure 3 Fourier transform infrared spectroscopy in B found that the composite scaffold contained characteristic absorption peaks of each component, indicating that the composite scaffold was effectively synthesized. Parotid mesenchymal stem cells (MSC) and parotid glandular epithelial cells (GEC) were recruited and adhered to the scaffold. The cells were fully extended, had more pseudopodia, and were attached to the surface of the material ( Figure 4 Calcein-AM-PI staining and laser confocal imaging showed that living cells aggregated in spherical shapes inside the scaffold ( Figure 5 A). KRT18 immunofluorescence staining and three-dimensional modeling revealed that the aggregation range of GEC on the scaffold gradually increased, showing glandular-like behavior in vitro ( Figure 5 B, C). CCK-8 results showed the proliferation behavior of salivary gland-derived cells on the scaffold. MSCs proliferated significantly over 7 days, with an S-shaped proliferation curve, while GECs did not proliferate significantly, which was consistent with the original biological behavior of the cells ( Figure 5 D).
[0047] After the establishment of the rat parotid gland trauma model, the gland atrophy occurred. The implantation of the stent can maintain the gland weight to a certain extent. After 20 days of implantation, the salivary flow rate of the stent repair group was significantly better than that of the trauma group and returned to the level of the control group. Astragalus polysaccharide loaded on the stent can significantly reduce tissue inflammatory response ( Figure 6 ). Histological staining results showed that in the scaffold repair group, a large amount of dark-stained silk protein was seen in the glands at 10 days, which was confirmed to be the implanted scaffold material. Cells could be seen growing into the micropores of the material. At 20 days, the dark-stained silk protein decreased, the material gradually degraded, and a large number of parotid cells grew into the micropores, clustering in an orderly manner in the pores of the material to form an alveolar-like structure ( Figure 7 A). COL-1 immunohistochemistry results showed that COL-1 formed a "chamber"-like structure around the acinar cells in the control group, surrounding the acinus and filling the interstitial part. In the trauma group, a large amount of fibrous connective tissue grew into the trauma site, and COL-1 staining was strongly positive. In the scaffold group, the scaffold material contained collagen components, which were COL-1 positive. The constructed microporous structure was a natural "chamber", providing a framework for the growth of acinar cells. At 20 days, cells could be seen gathering in the "chamber" and distributed in an orderly manner, and the structure gradually matured ( Figure 7 B).
[0048] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A three-dimensional acinar-like scaffold material for salivary gland regeneration and repair, characterized in that: The materials include: astragalus polysaccharide, silk fibroin and collagen; Optionally, the mass fractions of the astragalus polysaccharide, silk fibroin and collagen are 0.01-9.5%, 35-90% and 10%-40% respectively.
2. The acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair according to claim 1, characterized in that: The mass proportions of astragalus polysaccharide, silk fibroin and collagen are 4-5%, 59-60% and 35-36% respectively.
3. The acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair according to claim 1, characterized in that: The mass proportions of astragalus polysaccharide, silk fibroin and collagen are 4.8%, 59.5% and 35.7% respectively.
4. The acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair according to claim 1, characterized in that: There are two dimensional pore structures in the material, and the micropores imitate natural alveoli.
5. The acinus-mimicking three-dimensional scaffold material for salivary gland regeneration and repair according to claim 1, characterized in that: The material can achieve sustained release of astragalus polysaccharide.
6. A method for preparing a three-dimensional acinar-mimicking scaffold material for salivary gland regeneration and repair as claimed in claim 1, characterized in that: The method comprises the steps of low-temperature 3D printing and fractional freeze-drying.
7. A method for preparing a three-dimensional acinar-mimicking scaffold material for salivary gland regeneration and repair as claimed in claim 1, characterized in that: The method comprises the following steps: a. Extracting proteins from biological materials; b. Use low-temperature 3D printing to shape materials, design printing models and set 3D printing parameters; c. Setting freeze-drying parameters and using freeze-drying to obtain the microporous structure and drug loading space within the material; d. Using freeze drying in batches to evenly load astragalus polysaccharide; Optionally, the biomaterial of step a comprises bovine tendon and natural silk.
8. The preparation method according to claim 7, characterized in that: In step b, the setting parameters of 3D printing are: printing filling gap 1.3-1.5mm; edge gap 0.58-0.75mm, and the temperature of the receiving device is controlled at -30℃ to -10℃.
9. The preparation method according to claim 7, characterized in that: In step c, the freeze-drying treatment conditions are: condensation temperature < -60°C, vacuum degree < 15Pa; in step d, freeze-drying is performed before and after loading astragalus polysaccharide.
10. A use of the three-dimensional scaffold material for salivary gland regeneration and repair according to any one of claims 1 to 5 or the preparation method according to claims 6 to 9, characterized in that: The application is one or more of a) to d); a) Used for salivary gland regeneration and repair; b) Preparation of drugs for salivary gland regeneration and repair; c) For the treatment of salivary gland tumors, chronic inflammation of the salivary glands, or to alleviate the side effects of radiotherapy in patients with head and neck tumors; d) Preparation of a medicament for treating salivary gland tumors, chronic inflammation of the salivary glands or for alleviating the side effects of radiotherapy in patients with head and neck tumors; Optionally, the method is optionally used for non-diagnostic purposes or non-therapeutic purposes.
